Who Owns Phibro Company?

Who Owns Phibro Animal Health Corporation?

Understanding a company's ownership is key to grasping its strategy and accountability. Phibro Animal Health Corporation, a global animal health and mineral nutrition firm, has seen its ownership evolve significantly since its origins.

The company, with a history tracing back to 1917, now operates as a publicly traded entity, impacting its shareholder base and governance structure.

Phibro Animal Health Corporation, headquartered in Teaneck, New Jersey, has a global reach, offering over 1500 products in more than 75 countries. As of July 25, 2025, the company boasts a market capitalization of $1.18 billion and reported trailing twelve-month revenue of $1.19 billion. With approximately 1,940 employees, Phibro's operations span various animal species, including poultry, swine, cattle, and aquaculture, providing solutions aimed at enhancing health and nutrition. Investors interested in the company's strategic positioning might find the Phibro BCG Matrix insightful for understanding its product portfolio dynamics.

Phibro Animal Health Corporation's origins trace back to 1917 with the establishment of Philipp Brothers Inc., a precursor entity. The company was formally incorporated in Delaware in 1946 as Phillip Brothers Chemicals, Inc. While precise details on the initial equity distribution among its founders are not publicly detailed, the company's early focus included significant expansion within the animal nutrition sector.

Founding Entity

The company's lineage began with Philipp Brothers Inc. in 1917. This early entity laid the groundwork for future operations.

Formal Incorporation

Phillip Brothers Chemicals, Inc. was officially incorporated in Delaware in 1946. This marked a significant step in its corporate development.

Early Expansion

The company's initial growth strategy heavily involved the animal nutrition market. This sector became a core area of focus.

Key Acquisition 1974

A notable early acquisition was Koffolk, an Israeli company specializing in animal nutrition. This move bolstered its presence in the sector.

Strategic Acquisition 2000

In 2000, Phibro acquired Pfizer Inc.'s global medicated feed additives business. This significantly strengthened its position in the animal health industry.

Name Change

The company officially transitioned its name to Phibro Animal Health Corporation in July 2003. This rebranding reflected its specialized focus.

The company's journey from its inception as Philipp Brothers Inc. in 1917 to its formal incorporation as Phillip Brothers Chemicals, Inc. in 1946, and subsequent rebranding to Phibro Animal Health Corporation in 2003, highlights a strategic evolution. Key acquisitions, such as Koffolk in 1974 and Pfizer's medicated feed additives business in 2000, were instrumental in shaping its market presence and solidifying its identity within the animal health sector. For a more detailed look at its historical development, you can refer to the Brief History of Phibro.

Complete Phibro Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Phibro Animal Health Corporation's journey to public ownership began with its initial public offering (IPO) on April 11, 2014, listing on the NASDAQ Global Market under the ticker 'PAHC'. This event marked a significant shift, transitioning the company from private hands to a publicly traded entity, raising approximately $125 million and setting the stage for a diversified ownership base.

The ownership landscape of Phibro Animal Health Corporation is characterized by a blend of institutional, public, and insider holdings, with a notable concentration of voting power retained by a founding family. This structure influences the company's governance and strategic decision-making, balancing broad market participation with concentrated control.

Key Stakeholders in Phibro Animal Health

The Bendheim family, through BFI Co., LLC, holds a dominant position in Phibro Animal Health's ownership, primarily due to their significant holdings of Class B common stock. This class of stock carries ten votes per share, granting them substantial control over the company's direction.

• The Bendheim family, via BFI Co., LLC, is the majority owner of the company's voting power.
• Jack C. Bendheim, as Chairman and CEO, is the largest individual shareholder with 53.22% ownership.
• As of February 12, 2024, BFI Co., LLC held 20,166,034 shares of Class B common stock.
• Major institutional investors such as BlackRock, Inc. and Vanguard Group Inc. are significant minority shareholders.
• BlackRock, Inc. held 3.69 million shares, representing 9.11% of the company's stock as of July 25, 2025.
• Vanguard Group Inc. owned 1.52 million shares, accounting for 3.75% of the total shares.
• Understanding these holdings is crucial for comprehending the company's Mission, Vision & Core Values of Phibro.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

The Board of Directors at Phibro Animal Health Corporation is structured to reflect significant shareholder influence, particularly from the Bendheim family. Jack C. Bendheim holds key leadership roles, underscoring his substantial stake and operational control.

Phibro Animal Health's voting power is concentrated due to a dual-class share structure, where Class B Common Stock carries ten votes per share compared to Class A's one vote. This arrangement classifies the company as a 'controlled company' under NASDAQ rules. As of February 12, 2024, Jack C. Bendheim, through BFI Co., LLC, beneficially owned 20,166,034 shares of Class B Common Stock, granting him considerable control over corporate decisions. This structure allows the Bendheim family to maintain significant influence over board appointments and major corporate actions, impacting the Growth Strategy of Phibro.

Understanding Phibro's Voting Power

Phibro Animal Health's ownership structure is heavily influenced by its dual-class stock system. This system is crucial for understanding who truly controls the company's direction.

• Class B shares hold 10 votes each, while Class A shares have 1 vote.
• This structure ensures a majority of voting power remains with specific Class B shareholders.
• Jack C. Bendheim, through BFI Co., LLC, held a significant portion of Class B shares as of February 2024.
• This concentration of voting power impacts major corporate decisions and board composition.
• Phibro Animal Health is considered a 'controlled company' due to this voting power distribution.

Phibro Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Phibro Animal Health Corporation has seen significant strategic shifts and evolving ownership trends over the past few years. A key development was the acquisition of Zoetis's Medicated Feed Additive (MFA) portfolio, which has demonstrably impacted the company's financial performance and ownership landscape.

Institutional investors remain a cornerstone of Phibro Animal Health's ownership structure, with a substantial number of shares held by entities such as BlackRock, Vanguard, and State Street as of July 25, 2025. Despite insider holdings, the company's dual-class share structure ensures continued control by the Bendheim family, influencing its overall ownership profile. The company's financial trajectory, including its Marketing Strategy of Phibro, is closely watched by these significant Phibro Animal Health stockholders.

Institutional Investor Dominance

Major institutions like BlackRock and Vanguard are key Phibro Animal Health investors. Their holdings represent a significant portion of the company's outstanding shares.

Family Control Structure

The Bendheim family maintains a controlling interest through a dual-class share system. This structure impacts the Phibro Animal Health company structure and decision-making.

Strategic Acquisition Impact

The acquisition of Zoetis's MFA portfolio has boosted Phibro Animal Health stock performance. This strategic move is a key factor in recent revenue growth.

Stock Performance and Dividends

Phibro Animal Health stock price has shown a strong upward trend. The company continues its practice of issuing quarterly cash dividends to shareholders.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE